A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak.
Dec 29, 2020
0
2
Clinical trials to determine the safety and efficacy of a COVID-19 vaccine candidate from American biotech company Novavax have begun in the United States and Mexico, the US National Institutes of Health (NIH) announced Monday.
Dec 29, 2020
0
3
The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled trial will enroll approximately 30,000 people at approximately ...
Dec 28, 2020
0
51
India's confirmed coronavirus cases have crossed 10 million with new infections dipping to their lowest levels in three months, as the country prepares for a massive COVID-19 vaccination in the new year.
Dec 19, 2020
0
3
The World Health Organization program to help get COVID-19 vaccines to all countries in need has access to nearly 2 billion doses of "promising" vaccine candidates, officials said Friday.
Dec 18, 2020
0
6
China plans to start opening its vaccination programme to members of the public in southwestern Sichuan province early next year, health officials said, despite the inoculations not yet receiving official approval.
Dec 18, 2020
0
2
CureVac CEO Franz-Werner Haas readily admits his German biotech firm is "a bit behind" in the COVID-19 vaccine race, despite using the same cutting-edge technology as rivals Moderna and Pfizer/BioNTech.
Dec 16, 2020
0
3
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
Dec 16, 2020
0
0
Americans began receiving Pfizer's COVID-19 vaccine this week, and many people are eagerly awaiting their turn at vaccination, which they see as a ticket to normalcy.
Dec 16, 2020
0
3
A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.
Dec 16, 2020
0
2
